50
Participants
Start Date
May 31, 2013
Primary Completion Date
September 30, 2015
Study Completion Date
September 30, 2015
Risperidone
The dosage for risperidone will be 1 mg to 6 mg per day. The dose of the risperidone will be based on the participant's clinical improvement and side effects.
Omega-3 capsules
The total daily dose for omega-3 subjects will be 740 mg of eicosapentanoic acid (EPA)and 400 mg of docosahexaenoic acid(DHA). This dose will start on day 1 and stay the same dose until study completion.
Placebo
The total daily dose for subjects assigned to placebo will be 2000 mg. This dose will start on day 1 and stay the same dose until study completion.
The Zucker Hillside Hospital, Glen Oaks
National Institute of Mental Health (NIMH)
NIH
National Alliance for Research on Schizophrenia and Depression
OTHER
Delbert Robinson
OTHER